21 C.F.R. § 862.1135

C-peptides of proinsulin test system.

Last amended: 2016Year: 2026Length: 87 wordsSubsections: 1Official source

Cite as 21 C.F.R. § 862.1135 (2026)

(a) Identification. A C-peptides of proinsulin test system is a device intended to measure C-peptides of proinsulin levels in serum, plasma, and urine. Measurements of C-peptides of proinsulin are used in the diagnosis and treatment of patients with abnormal insulin secretion, including diabetes mellitus. (b) Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9. [52 FR 16122, May 1, 1987, as amended at 65 FR 2305, Jan. 14, 2000]
Cross-references to the CFR
862.9.
21 C.F.R. § 862.1135: C-peptides of proinsulin test system. | Justis AI